Celanese stock holds steady as earnings and debt reduction shape outlook
Published on 07/23/2026 at 06:22 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS
Celanese Corp. (ISIN US1510201049) reported adjusted earnings per share of $2.08 in the fourth quarter of 2023, compared with $1.44 in the prior-year quarter, as the company continued to integrate the acquired Mobility & Materials portfolio and manage a higher debt load. According to the company’s full-year 2023 results released on 20 February 2024, this EPS improvement came despite softer demand in some end markets and higher interest costs.
Revenue of $10.9 billion in 2023
In its 2023 annual results, Celanese stated that full-year net sales reached $10.9 billion, up from $9.7 billion in 2022, driven mainly by the first full-year consolidation of the former Mobility & Materials business and pricing discipline across key product lines. The company also highlighted that its Engineered Materials segment benefited from expanded applications in automotive, electronics, and medical devices as volumes from the acquired portfolio were integrated into the broader platform.
Management reported that adjusted EBITDA for 2023 was approximately $2.7 billion, compared with roughly $2.2 billion in 2022, as cost synergies and productivity measures helped offset weaker volumes in certain industrial and consumer markets. Celanese emphasized that the synergy capture from the Mobility & Materials integration was ahead of its original timeline, supporting both margin resilience and cash generation.
Net earnings and margin trends
For the full year 2023, Celanese recorded net earnings attributable to the company of around $1.1 billion, versus roughly $1.0 billion in 2022, reflecting the effect of higher operating profits and higher interest expenses following the acquisition financing. The company’s adjusted EBITDA margin for 2023 was reported in the mid-twenties percent range, slightly lower than the level achieved in 2022 as weaker demand and higher input costs weighed on some product lines.
In the fourth quarter of 2023, net sales were approximately $2.6 billion, broadly in line with the same period of 2022, while the adjusted EBITDA margin improved year over year due to cost actions and pricing discipline. The company noted that sequential margin improvement in Engineered Materials was a key focus, with demand in transportation applications stabilizing and the benefits of portfolio optimization becoming more visible in the second half of the year.
Further coverage on Celanese
More company news, regulatory filings, and financial data on Celanese are available through the dedicated topic page and the company’s own Investor Relations section.
Debt of about $13 billion after acquisition
Following the acquisition of the Mobility & Materials business from DuPont, Celanese’s reported total debt rose to approximately $13 billion at the end of 2023, compared with roughly $4 billion before the transaction closed in 2022. The company explained that it used a mix of term loans, bonds, and other instruments to finance the deal, which transformed its balance sheet and increased leverage but also boosted scale, product breadth, and customer reach.
Celanese has communicated a medium-term target to reduce its net debt to adjusted EBITDA ratio to around 3 times, compared with a level closer to 4 times immediately after the acquisition, by using free cash flow to pay down borrowings and moderating capital expenditures. Management pointed to 2023 free cash flow generation in the hundreds of millions of dollars and emphasized that additional deleveraging is expected as integration synergies ramp up and markets normalize from cyclical lows.
Dividend and shareholder returns
Celanese paid a regular quarterly dividend of $0.70 per share in 2023, or $2.80 per share on an annualized basis, in line with the level it has maintained since an increase implemented in 2022. On the basis of the company’s full-year 2023 adjusted EPS of roughly $9, the dividend payout ratio was therefore around 31%, giving the company flexibility to fund capital expenditures and debt reduction while still returning cash to shareholders.
The company has also used share repurchases in past years as part of its capital allocation framework, though buyback activity has been more limited since the acquisition as the focus shifted toward balance-sheet repair. Management has indicated that once leverage returns to the targeted range, it may reassess the mix of dividends, share repurchases, and investment spending, but deleveraging remains the immediate priority.
Acetyl chain underpins cash generation
The Acetyl Chain segment remains a key earnings and cash driver for Celanese, supplying acetic acid, vinyl acetate monomer, and derivatives used across adhesives, coatings, and industrial applications. In 2023, segment net sales were in the multi-billion-dollar range, and the business continued to deliver solid margins despite lower volumes in construction and consumer end markets.
Celanese continues to invest in debottlenecking and efficiency projects in its acetyl network, including facilities in North America, Europe, and Asia, to lower unit costs and improve reliability. These projects, together with disciplined supply chain management, are designed to enhance the segment’s ability to generate stable cash flows across cycles, helping to fund the company’s broader growth and deleveraging plans.
Engineered Materials and Mobility & Materials
The Engineered Materials segment, which now incorporates the acquired Mobility & Materials operations, focuses on high-performance polymers used in automotive, electronics, medical, and consumer applications. In 2023, Celanese reported that this combined portfolio generated several billion dollars of net sales, with a product mix that includes polyoxymethylene, nylon, and other specialty engineering plastics.
Integration activities have included rationalizing overlapping product lines, aligning commercial strategies, and capturing procurement and operational synergies. Celanese has cited a synergy target measured in the hundreds of millions of dollars annually and stated that a substantial portion of this target had already been realized by the end of 2023, contributing to the year-over-year increase in adjusted EBITDA.
Guidance and 2024 focus
For 2024, Celanese has framed its outlook around continued improvement in adjusted EBITDA, further realization of integration synergies, and steady progress in reducing net debt, though it has acknowledged that macroeconomic uncertainty and uneven demand conditions remain a factor. The company’s guidance framework points to modest volume growth in key end markets such as automotive and medical, with price and mix expected to remain disciplined.
Investors in Celanese stock are likely to track how quickly the company can approach its net debt to adjusted EBITDA leverage target and whether margin performance in the Engineered Materials and Acetyl Chain segments remains resilient as markets evolve. The development of free cash flow, including working-capital discipline and capital expenditure levels, will also be an important indicator of how much flexibility the company has to balance growth investments, debt repayment, and shareholder returns.
Representative product portfolio in engineering polymers
Celanese offers a broad range of engineering polymers, including acetal copolymers and other high-performance materials used in fuel systems, electrical connectors, medical devices, and industrial machinery. These products are designed to provide durability, chemical resistance, and dimensional stability, supporting the company’s positioning in applications where reliability and performance are critical.
Celanese stock and trading venue
Celanese stock is listed on the New York Stock Exchange under the ticker CE and trades in US dollars, giving international investors access through one of the most liquid US equity markets. The company’s market capitalization stands in the multiple billions of dollars range, reflecting its scale in specialty materials and the market’s assessment of its earnings power, integration progress, and balance-sheet strategy.
Key facts about Celanese
- Company: Celanese Corp.
- ISIN: US1510201049
- Ticker: NYSE: CE
- Trading venue: NYSE
- Sector / Industry: Materials / Specialty Chemicals
- Index membership: S&P 500
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
